Quality of Life in Japanese Pediatric Alopecia Areata

Quality of Life Survey in Japanese Children with Alopecia Areata: A Non-Interventional Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1030230428

Enrollment

300

Registered

2023-11-03

Start date

2023-11-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric alopecia areata Pediatric, alopecia areata, Pfizer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed with AA and age 5 to 15 years

Exclusion criteria

Exclusion criteria: Have primarily diffuse type of AA (characterized by widespread reduction of hair density rather than clearly defined patches of hair loss). 2. Are currently experiencing other forms of alopecia including, but not limited to, telogen effluvium, chemotherapy-induced hair loss, or any other concomitant conditions (for example, Down syndrome, tinea capitis, psoriasis, lupus erythematosus, or secondary syphilis) that would interfere with the evaluation of the effect of study medication on AA.

Design outcomes

Primary

Measure	Time frame
Children's Dermatology Life Quality Index (CDLQI)	—

Secondary

Measure	Time frame
- Subpopulation analysis of CDLQI and Pediatric Quality of Life Inventory(PedsQL) scores per hair loss range - Comparison of CDLQI and Family Dermatology Life Quality Index(FDLQI) - Comparison of PedsQL results between the child own reports and the parent proxy reports	—

Contacts

Public ContactAtsuko Ono

3H Medi Solutions Inc.

ono-atsuko@3h-ms.co.jp+81-80-3017-5063

Outcome results